A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group, 2-part Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Inhaled Doses of AZD9819 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 08 Nov 2011
At a glance
- Drugs AZD 9819 (Primary)
- Indications Asthma
- Focus Adverse reactions
- 25 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Sep 2010 Actual initiation date (Aug 2010) added as reported by ClinicalTrials.gov.
- 15 Sep 2010 Planned end date changed from 1 Dec 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.